Unibest
← Back to patent-cliff list

Soclenicant

Tier C — Watch / trade

Soclenicant

Bionomics Ltd
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:nAChRα7

Indications (approved):Post-traumatic stress disorder, 社交恐惧症, Agitation

Regional status

US
Phase II
2016-06-30
EU
Phase II
2021-07-27
China
-
Japan
-

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 10 · Total yield /
BNC-210-001609-71-2BNC-210-0026854-07-5BNC-210-00342959-38-6BNC-210-0041020635-54-4BNC-210-0051020636-41-2BNC-210-0066148-64-7BNC-210-0071397177-40-0BNC-210-008—BNC-210-0091020635-70-4BNC-210-0101020635-78-2BNC-210-011615-13-4BNC-210-0121020635-22-6BNC-2101020634-41-6API · Soclenicant
CodeCAS No.Intermediate
BNC-210-001609-71-22-hydroxynicotinic acid
BNC-210-0026854-07-52-hydroxy-5-nitronicotinic acid
BNC-210-00342959-38-62-chloro-5-nitronicotinic acid
BNC-210-0041020635-54-42-methoxy-5-nitronicotinic acid
BNC-210-0051020636-41-22-methoxy-5-nitronicotinoyl chloride
BNC-210-0066148-64-7Availablepotassium 3-ethoxy-3-oxopropanoate
BNC-210-0071397177-40-0ethyl 3-(2-methoxy-5-nitropyridin-3-yl)-3-oxopropanoate
BNC-210-008-(Z)-ethyl 3-ethoxy-2-(2-methoxy-5-nitronicotinoyl)acrylate
BNC-210-0091020635-70-4ethyl 1-ethyl-6-nitro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate
BNC-210-0101020635-78-2ethyl 6-amino-1-ethyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate
BNC-210-011615-13-4Available1H-inden-2(3H)-one
BNC-210-0121020635-22-6ethyl 6-((2,3-dihydro-1H-inden-2-yl)amino)-1-ethyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate
BNC-2101020634-41-61,8-Naphthyridin-4(1H)-one, 6-[(2,3-dihydro-1H-inden-2-yl)amino]-1-ethyl-3-(4-morpholinylcarbonyl)-

Frequently asked questions

What are the approved indications of Soclenicant?

Approved indications include: Post-traumatic stress disorder, 社交恐惧症, Agitation.

When does the Soclenicant patent expire?

No public expiry year is available for Soclenicant yet; this page updates once verified.

How many synthesis routes are recorded for Soclenicant?

1 synthesis routes are recorded; the shortest is 10 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Soclenicant intermediates?

2 intermediate CAS of Soclenicant are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Soclenicant intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-10